Get the Stockscreener App
1.01
7.34%
-0.08
After Hours:
1.01
Gelteq Ltd stock is traded at $1.01, with a volume of 39,916.
It is down -7.34% in the last 24 hours and down -4.72% over the past month.
Gelteq Ltd is a clinical and science-based company focused on developing and commercializing white label gel-based delivery solutions for prescription drugs, nutraceuticals, pet care and other products, preserving the simplicity, accessibility, and efficacy of oral delivery. Its principal products are edible gels and their application in gel-based dosage forms across pets, sports, pharmaceutical, over-the-counter, and nutraceutical categories, leveraging its patent pending multiple ingredient dosage forms. The company develops and tests gel-based delivery systems for humans and pets and focuses on out-licensing its technology to companies to create products that can be manufactured and sold, while continuing to manufacture existing products under license on a white label basis.
See More
Previous Close:
$1.09
Open:
$1.06
24h Volume:
39,916
Relative Volume:
0.04
Market Cap:
$10.82M
Revenue:
-
Net Income/Loss:
-
P/E Ratio:
-
EPS:
-
Net Cash Flow:
-
1W Performance:
-7.34%
1M Performance:
-4.72%
6M Performance:
-56.09%
1Y Performance:
-66.89%
1-Day Range:
$1.00
$1.0899
1-Week Range:
$1.00
$1.19
52-Week Range:
$0.7701
$4.11
Gelteq Ltd Stock (GELS) Company Profile
Compare GELS with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
GELS
Gelteq Ltd
|
1.01 | 11.68M | 0 | 0 | 0 | 0.00 |
|
ZTS
Zoetis Inc
|
118.66 | 51.85B | 9.40B | 2.65B | 2.24B | 5.935 |
|
TAK
Takeda Pharmaceutical Co Adr
|
14.33 | 45.46B | 29.63B | 260.53M | 5.51B | 0.0788 |
|
HLN
Haleon Plc Adr
|
9.52 | 42.70B | 14.26B | 1.98B | 2.47B | 0.4327 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
29.79 | 34.62B | 16.70B | -157.13M | 1.19B | -0.1446 |
|
UTHR
United Therapeutics Corp
|
493.99 | 21.03B | 3.08B | 1.24B | 1.07B | 25.61 |
Gelteq Ltd Stock (GELS) Latest News
Gelteq Signs Three Year Sales Agreement with Shenzhen Mana Health Management Co. Strengthening Gelteq’s Nutritional Product Expansion into China - Asianet Newsable
Gelteq to Present at Investor Summit Virtual on December 9, 2025 - Asianet Newsable
Gelteq Preclinical Study Demonstrates Enhanced Oral Delivery of Oil-Soluble and Poorly Soluble Drugs Using Its Gel-Based Platform - Stocktwits
Gelteq signs $1.3 million distribution deal for nutritional products in China - Investing.com Australia
Gelteq reports promising results for oral gel drug delivery platform By Investing.com - Investing.com India
Gelteq stock rises after preclinical data shows enhanced drug delivery By Investing.com - Investing.com South Africa
Gelteq (GELS) preclinical gel platform lifts oral bioavailability 300% vs FDA drug - Stock Titan
Gelteq Limited (GELS) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade
Taking on analysts’ expectations and winning: Gelteq Ltd (GELS) - Setenews
A Look at Planet Green Holdings Corp (PLAG) Shares in the Recent Past Indicates Growth - Setenews
Kartoon Studios Mainframe Studios, Toon Media, and Premium IP Pipeline Drive 2026-2027 Outlook - Markets Financial Content
12 Health Care Stocks Moving In Monday's Intraday Session - Benzinga
AMAZE AND LOFT 100 STUDIOS PARTNER TO BRING WORLD-CLASS LIVE PRODUCTION STUDIOS TO CREATORS - Stocktwits
Bridger Aerospace Secures Purchase Agreement for Two Spanish Super Scoopers, Bolstering Aerial Firefighting Power and Paving the Way for 2026 Expansion - Stocktwits
Gelteq Announces Positive Preclinical Results Demonstrating Enhanced Bioavailability Using Its Proprietary Gel-Based Drug Delivery Platform - Stocktwits
You might want to take a look at Zooz Strategy Ltd (ZOOZ) now - Setenews
Why Gelteq Limited stock appeals to dividend seekersQuarterly Portfolio Report & Daily Volume Surge Signals - newser.com
How moving averages guide Gelteq Limited tradingBuy Signal & Accurate Entry/Exit Alerts - newser.com
Is Gelteq Limited a candidate for recovery playWeekly Gains Summary & Detailed Earnings Play Strategies - newser.com
Will Gelteq Limited stock remain a Wall Street favorite2025 Big Picture & Free Daily Entry Point Trade Alerts - newser.com
Is a relief rally coming for Gelteq Limited holdersTrade Risk Assessment & Low Risk High Win Rate Picks - newser.com
Will Gelteq Limited stock benefit from green energy trendsCEO Change & Daily Stock Trend Reports - newser.com
Is Gelteq Limited stock supported by strong fundamentalsStop Loss & Growth Focused Stock Pick Reports - newser.com
Why Gelteq Limited stock could be next big winner2025 Macro Impact & Verified Entry Point Detection - Fundação Cultural do Pará
Will Gelteq Limited stock recover faster than peers2025 Price Action Summary & Real-Time Buy Zone Alerts - Fundação Cultural do Pará
Will Gelteq Limited stock continue dividend increases2025 Top Decliners & Risk Controlled Daily Plans - newser.com
GCL Announces ‘Island of Hearts’, a Live-Action Interactive Adventure Coming To PC - Stocktwits
Will Gelteq Limited stock reach all time highs in 2025July 2025 Momentum & Weekly Breakout Stock Alerts - newser.com
Key metrics from Gelteq Limited’s quarterly data2025 Technical Overview & Stepwise Trade Signal Implementation - newser.com
Gelteq Announces New Product Development Agreement with Melbourne Health for Novel Bowel Polyp Growth Reduction Compound - MSN
How Does Wall Street Rate Shares Of Gelteq Ltd (GELS)? - fostersleader.com
ZenaTech to Highlight Drone as a Service, AI Drone Solutions, and US Defense Initiatives at Three Upcoming Investor Conferences - Stocktwits
Aduro Clean Technologies Provides Update on NGP Pilot Plant Commissioning - Stocktwits
What margin trends mean for Gelteq Limited stockWeekly Gains Report & Smart Swing Trading Techniques - newser.com
Gelteq Ltd Stock (GELS) Financials Data
There is no financial data for Gelteq Ltd (GELS). Check out other stocks for more information.
Revenue
Net Income
Cash Flow
EPS
1.48%
0.09%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):